Reagents for Mass Cytometry

被引:23
|
作者
Arnett, Loryn P. [1 ]
Rana, Rahul [1 ]
Chung, Wilson Wai-Yip [1 ]
Li, Xiaochong [1 ]
Abtahi, Mahtab [1 ]
Majonis, Daniel [3 ]
Bassan, Jay [1 ]
Nitz, Mark [1 ]
Winnik, Mitchell A. [1 ,2 ]
机构
[1] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada
[2] Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada
[3] Stand BioTools Canada Inc, Markham, ON L3R 4G5, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
SEMICONDUCTING POLYMER DOTS; UP-CONVERSION NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; ELEMENT-TAGGED IMMUNOASSAY; METAL-ORGANIC-FRAMEWORK; SILVER NANOPARTICLES; RUTHENIUM TETROXIDE; FLOW-CYTOMETRY; ICP-MS; UPCONVERTING NANOPARTICLES;
D O I
10.1021/acs.chemrev.2c00350
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Mass cytometry (cytometry by time-of-flight detection [CyTOF]) is a bioanalytical technique that enables the identification and quantification of diverse features of cellular systems with single-cell resolution. In suspension mass cytometry, cells are stained with stable heavy-atom isotope-tagged reagents, and then the cells are nebulized into an inductively coupled plasma time-of-flight mass spectrometry (ICP-TOF-MS) instrument. In imaging mass cytometry, a pulsed laser is used to ablate ca. 1 mu m2 spots of a tissue section. The plume is then transferred to the CyTOF, generating an image of biomarker expression. Similar measurements are possible with multiplexed ion bean imaging (MIBI). The unit mass resolution of the ICP-TOF-MS detector allows for multiparametric analysis of (in principle) up to 130 different parameters. Currently available reagents, however, allow simultaneous measurement of up to 50 biomarkers. As new reagents are developed, the scope of information that can be obtained by mass cytometry continues to increase, particularly due to the development of new small molecule reagents which enable monitoring of active biochemistry at the cellular level. This review summarizes the history and current state of mass cytometry reagent development and elaborates on areas where there is a need for new reagents. Additionally, this review provides guidelines on how new reagents should be tested and how the data should be presented to make them most meaningful to the mass cytometry user community.
引用
收藏
页码:1166 / 1205
页数:40
相关论文
共 50 条
  • [31] Mass cytometry markers for stratification of RA?
    McHugh J.
    Nature Reviews Rheumatology, 2019, 15 (9) : 512 - 512
  • [32] Aptamer-facilitated mass cytometry
    Gleb G. Mironov
    Alexandre Bouzekri
    Jessica Watson
    Olga Loboda
    Olga Ornatsky
    Maxim V. Berezovski
    Analytical and Bioanalytical Chemistry, 2018, 410 : 3047 - 3051
  • [33] A Practical Guide to Multiplexed Mass Cytometry
    Zivanovic, Nevena
    Jacobs, Andrea
    Bodenmiller, Bernd
    HIGH-DIMENSIONAL SINGLE CELL ANALYSIS: MASS CYTOMETRY, MULTI-PARAMETRIC FLOW CYTOMETRY AND BIOINFORMATIC TECHNIQUES, 2014, 377 : 95 - 109
  • [34] Mass cytometry: blessed with the curse of dimensionality
    Evan W Newell
    Yang Cheng
    Nature Immunology, 2016, 17 : 890 - 895
  • [35] Titrating Complex Mass Cytometry Panels
    Gullaksen, Stein-Erik
    Bader, Lucius
    Hellesoy, Monica
    Sulen, Andre
    Fagerholt, Oda Helen Eck
    Engen, Caroline B.
    Skavland, Jorn
    Gjertsen, Bjorn Tore
    Gavasso, Sonia
    CYTOMETRY PART A, 2019, 95A (07) : 792 - 796
  • [36] Genesis of the Special Issues on Mass Cytometry
    Preffer, Frederic
    Tarnok, Attila
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2017, 92 (01) : 9 - 9
  • [37] Highly multiparametric analysis by mass cytometry
    Ornatsky, Olga
    Bandura, Dmitry
    Baranov, Vladimir
    Nitz, Mark
    Winnik, Mitchell A.
    Tanner, Scott
    JOURNAL OF IMMUNOLOGICAL METHODS, 2010, 361 (1-2) : 1 - 20
  • [38] Mass cytometry: The time to settle down
    Cosma, Antonio
    Nolan, Garry
    Gaudilliere, Brice
    CYTOMETRY PART A, 2017, 91A (01) : 12 - 13
  • [39] Cell size assays for mass cytometry
    Stern, Alan D.
    Rahman, Adeeb H.
    Birtwistle, Marc R.
    CYTOMETRY PART A, 2017, 91A (01) : 14 - 24
  • [40] From mass cytometry to cancer prognosis
    Deborah R Winter
    Guy Ledergor
    Ido Amit
    Nature Biotechnology, 2015, 33 : 931 - 932